PPARG and fatty liver disease: The observations above indicate that PPARγ regulates the expression of the downstream target (CD36), thereby enabling TAG deposition and affecting lipid metabolism in the liver and plays a vital role in the occurrence of fatty liver disease (Wang et al., unpublished data; Figure 1).